Delivery Vehicles

Probiotics are live microorganisms which confer a health benefit on the host when administered in an adequate amount. Over the past decades, the market size of probiotics has greatly increased as modern consumer concern about health-promoting effect of nutraceuticals. Since probiotic-containing products in general do not require Food and Drug Administration approval, they are commonly available in the market in various food formats such as fermented milk, cheese, yogurt and juice. In recent years, probiotics have been extensively studied as a treatment option of various diseases such as obesity, diabetes, cancer, human immunodeficiency virus infection, irritable bowel syndrome. For probiotics to exert beneficial activities, a sufficient amount of probiotics should be alive and functionally active at the site of action as well as in a product. Probiotics are recommended to be present at a minimum level of 6 log colony forming unit (CFU)/g in a food product or 7 log CFU/g at the point of delivery. Due to the vulnerability of probiotics to harsh conditions during manufacturing, storage and passage through the gastrointestinal (GI) tract, however, it is difficult that viable probiotics successfully exert beneficial activities. During manufacturing and/or storage, the viability of probiotics can be negatively affected by several factors such as temperature, water activity and other food ingredients. Specifically, high temperature during manufacturing processes is a main reason for reduced viability because most probiotics have low thermo-resistance. Maintaining viability in the stomach is another difficult task for probiotics to reach the target site because most of probiotics die or lose their functionality at acidic conditions. Next, survived probiotics should be released at the target site of action which is usually small or large intestine. Therefore, an ideal probiotic delivery system should protect probiotics from adverse conditions during fabrication and storage and in the acidic gastric environment so that the sufficient amount of probiotics is available in the site of action.

  • Probiotics as antigen delivery vehicles
  • Probiotics as delivery vehicles for neuroactive compounds
  • Encapsulation of probiotics in to carrier material
  • Non microencapsulation-based technology
  • Food Formats for effective delivery of Probiotics
  • Probiotic delivery systems
  • Recent trends of probiotics delivery systems
  • Dairy products as delivery vehicle for probiotics and biogenic substances
  • Oral Vaccine Delivery by Recombinant Spore Probiotics
  • LAB as Vehicles for Anti-IBD Compounds

Related Conference of Delivery Vehicles

February 12-13, 2020

31st World Congress on Nutrition & Food Sciences

Auckland, Newzealand
February 24-25, 2020

23rd World Congress on Nutrition and Food Sciences

Tokyo, Japan
March 26-27, 2020

24thAsia Pacific
Nutrition Meet and Expo

Kyoto, Japan
April 13-14, 2020

31st Annual Congress on Nutrition & Food Sciences

Bangkok, Thailand
April 13-14, 2020

29thWorld Congress on Diet, Nutrition and Obesity

Auckland, Newzealand
April 20-21, 2020

26th European Nutrition and Dietetics Conference

Berlin, Germany
May 13-14, 2020

21st International Congress on Nutrition and Health

| Zagreb, Croatia
June 15-16, 2020

3rd World Congress on Food and Nutrition

Dubai, UAE
June 22-23, 2020

29th World Congress on Nutrition & Dietetics

Sydney, Australia
September 17-18, 2020

2nd World Congress on Child Nutrition and Health

Vienna, Austria
September 23-24, 2020

19th World Congress on Nutrition and Food Chemistry

Rome, Italy
September 25-26, 2020

Fisheries 2020

Vancouver, Canada
October 26-27, 2020

World Congress on Nutrition & Eating Disorders

Tokyo, Japan
October 26-27, 2020

Annual meet on Epidemiology and Public Health

Osaka, Japan
November 29-30, 2020

Functional Food and Advanced Nutrition 2020

Beijing, China

Delivery Vehicles Conference Speakers

Recommended Sessions

Related Journals

Are you interested in